Medindia
Medindia LOGIN REGISTER
Advertisement

QED International Associates Announces Changes to the HealthShares(TM) GI/Gender Health Index

Wednesday, February 27, 2008 General News
Advertisement
NEW YORK, Feb. 26 QED International Associates, Inc,administrator for the HealthShares(TM) Indexes, a series of 20 underlyingindexes for the HealthShares(TM) Exchange-Traded Funds, today announced thateffective at the opening of trading on Friday February 29, 2008, UCB SA(Brussels: UCB.BR) will replace Axcan Pharma, Inc. (Nasdaq (GS): AXCA) in theHealthShares(TM) GI/Gender Health Index. Axcan Pharma is being acquired by anaffiliate of TPG Capital, a leading private investment firm founded in 1992.
Advertisement

Companies included in the GI/Gender Health Index are engaged in theresearch, clinical development and/or commercialization of therapeutic agentsfor the treatment of a wide variety of diseases including, but not limited to,gastrointestinal disorders such as gastroesophageal reflux disease, heartburn,irritable bowel syndrome, Crohn's Disease and ulcerative colitis;genitourinary disorders such as overactive bladder, urge incontinence, stressincontinence and urinary tract infection; and gender health matters includingsexual dysfunction (male and female), endometriosis, benign prostatichyperplasia, prolapsed womb and reproductive health..
Advertisement

About QED International Associates

QED International Associates, based in New York, is a leading financialindustry consulting firm specializing in quantitative modeling and the design,development and maintenance of indexes and Exchange Traded Funds. For moreinformation, visit the company's website at www.qedinternational.com

SOURCE QED International Associates
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close